Clinical trial · Interventional
Obstetrical Gel Use to Shorten Labor and Prevent Lower Genital Tract Trauma
Obstetrical Gel Use to Shorten Labor and Prevent Lower Genital Tract Trauma: A Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Recent literature shows that birth injury is associated with postpartum pelvic floor dysfunction (pelvic organ prolapse and fecal and urinary incontinence). Prolonged labor, namely during the 2nd stage, is one of the main obstetric risk factors responsible for anal sphincter rupture and fecal incontinence. In addition, it is associated with increased maternal and neonatal morbidities including increased risk of lower genital tract lacerations. In an effort to shorten labor and decrease lower genital tract trauma many techniques have been investigated. The objective of our study is to investigate whether the use of obstetric gel shortens the first and second stage of labor and exerts a protective effect on the lower genital tract. Neonatal and maternal morbidities will be also assessed. The study design will be a randomized controlled trial of 2 groups, where the patients presenting for vaginal delivery will be randomly assigned to either: * Group 1 who will receive the standard care during labor and delivery * Group 2 who will receive the standard care during labor and delivery with the vaginal application of the obstetrical gel The goal of this randomized controlled study is to compare the length of the first and 2nd stage of labor and the lower genital tract integrity in the 2 groups of patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Labor Stage, Second | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Natalis | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Group 1
- description
- Group 1 in which they will receive the standard care during labor and delivery without the use of the obstetrical gel
- type
- EXPERIMENTAL
- label
- Group 2
- description
- Group 2 in which they will have the standard care during labor and delivery with the vaginal application of the obstetrical gel according to the study protocol. Those 2 groups will be further divided into 4 subgroups where the parity will be accounted for (nulliparous \[never delivered beyond 20 weeks of gestation in a previous pregnancy\] or primiparous or more)
- interventionNames
- Drug: Natalis
Primary outcomes (1)
- measure
- Reduction in the length of the second stage of labor
- timeFrame
- Second stage of labor, a reduction to 39.9 minutes from a calculated average of 66.5 minutes
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * Age between 18 and 40 years * Intended vaginal delivery * Singleton baby in vertex presentation * Low risk pregnancy at term (37-42 weeks of gestation) * Estimated birth weight between 2000 g and 4500 g (clinically or by sonography) * Signed written informed consent Exclusion Criteria: * Contraindications for vaginal delivery (placenta previa, active herpes infection, etc…) * Advanced cervical dilation (≥ 5 cm) * Suspected amniotic infection (fever, foul smelling discharge, fetal tachycardia, abdominal pain) * Non reassuring fetal heart tracing * Prolonged rupture of the membranes (24 hours) * Suspected major fetal malformations * Suspected cephalopelvic disproportion
References
Publications (0)
Data not yet available